Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NPSP NPS Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (71)	2/15/2000 2:39:00 PM
From: scaram(o)uche	Respond to of 363

2000 patients! not mucking around, going for the data. new disclosures (SC 13G) out, haven't had time to look at them.

To: biowa who wrote (71)	2/15/2000 8:41:00 PM
From: Biotech Jim	Read Replies (1) \| Respond to of 363

I always thought that PTH when given chronically to rats resulted in bone breakdown, whereas pulsatile PTH like that that is naturally secreted builds up bone (in concert with 1,25-dihydroxycholecalciferol). Therefore I am a bit confused about this work and the clinical trial that is to be started. Has anyone spoken with the company about this issue, particularly relating to this natural hormone's formulation for these studies? BJ